Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5535)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2023 (publication date) through Apr 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dietrich CG, Geier A, Merle U. Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? World J Gastroenterol 2023; 29(2): 367-377 [PMID: 36687116 DOI: 10.3748/wjg.v29.i2.367] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i2/367.htm |
| Number | Citing Articles |
| 1 |
Mandal Avishek. Prospective Coronavirus Liver Effects: Available Knowledge. Annals of Clinical Gastroenterology and Hepatology 2023; 7(1): 001 doi: 10.29328/journal.acgh.1001039
|
| 2 |
Fernanda Manhães Pozzobon, Ronir Raggio Luiz, Júlia Gomes Parente, Taísa Melo Guarilha, Maria Paula Raymundo Cunha Fontes, Renata de Mello Perez, Maria Chiara Chindamo. Is Steatotic Liver Disease Related to Poor Outcome in COVID-19-Hospitalized Patients?. Journal of Clinical Medicine 2024; 13(9): 2687 doi: 10.3390/jcm13092687
|
| 3 |
J. Collin Fishman, Christina Qian, Yestle Kim, Hannah Rochon, Shelagh M. Szabo, Rosie Sun, Michael Charlton. Cost burden of cirrhosis and liver disease progression in metabolic dysfunction–associated steatohepatitis: A US cohort study. Journal of Managed Care & Specialty Pharmacy 2024; 30(9): 929 doi: 10.18553/jmcp.2024.24069
|
| 4 |
Ludovico Abenavoli, Isabella Aquila, Matteo Antonio Sacco, Giuseppe Guido Maria Scarlata, Anna Caterina Procopio, Luigi Boccuto, Emidio Scarpellini, Marta Greco, Daniela Patrizia Foti, Pietrantonio Ricci, Francesco Luzza. Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series. Diseases 2023; 11(4): 141 doi: 10.3390/diseases11040141
|
| 5 |
О. О. Чукур, Н. В. Пасєчко, А. О. Боб. КОРЕКЦІЯ ТИРЕОЇДНОЇ ДИСФУНКЦІЇ ТА МЕТАБОЛІЧНИХ ПОРУШЕНЬ У ЖІНОК ПЕРИМЕНОПАУЗАЛЬНОГО ВІКУ З ГІПОТИРЕОЗОМ. Здобутки клінічної і експериментальної медицини 2023; (4): 155 doi: 10.11603/1811-2471.2023.v.i4.14310
|
| 6 |
Michele Walsh, Deborah John, Nicole Peritore, Andrea Morris, Carolyn Bird, Marion Ceraso, Sarah Eichberger, Rachel Novotny, Laura Stephenson, Suzanne Stluka, Roberta Riportella. Health in All Policies: Working Across Sectors in Cooperative Extension to Promote Health for All. Journal of Human Sciences and Extension 2018; doi: 10.54718/RYTE6013
|
| 7 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
Abstract(716) |
Core Tip(688) |
Full Article(HTML)(3659)
|
Full Article with Cover (PDF)-1825K(209)
|
Full Article (Word)-130K(37)
|
Audio-14227K(22)
|
Peer-Review Report-222K(86)
|
Answering Reviewers-194K(67)
|
Full Article (PDF)-407K(194)
|
Full Article (XML)-119K(90)
|
Times Cited (0)
|
Total Visits (10980)
|
Open
|
| 8 |
Є. С. Сірчак, А. В. Стегура. ОЦІНКА ЕФЕКТИВНОСТІ КОМПЛЕКСНОЇ ТЕРАПІЇ ІЗ ВИКОРИСТАННЯМ ПРОБІОТИКА ТА РЕБАМІПІДУ НА ДИНАМІКУ БІОЛОГІЧНИХ МАРКЕРІВ УРАЖЕННЯ КИШЕЧНИКА ТА ДИСБІОТИЧНІ ЗМІНИ У ХВОРИХ НА НЕАЛКОГОЛЬНУ ЖИРОВУ ХОРОБУ ПЕЧІНКИ ПІСЛЯ СOVID-19. Здобутки клінічної і експериментальної медицини 2023; (4): 136 doi: 10.11603/1811-2471.2023.v.i4.14309
|
| 9 |
Mohamad Abdelkhalik, Samah Al Tawil, Adam El Fouani, Nour Allakiss, Lama Mattar, Wissam H. Faour, Rajaa Chatila, Aleksandra Klisic. Unveiling metabolic dysfunction-associated fatty liver disease: Knowledge gaps and attitudes among Lebanese university students. PLOS ONE 2024; 19(8): e0306825 doi: 10.1371/journal.pone.0306825
|
| 10 |
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler. Cholesterol and Cholesterol-Lowering Medications in COVID-19—An Unresolved Matter. International Journal of Molecular Sciences 2024; 25(19): 10489 doi: 10.3390/ijms251910489
|
| 11 |
Jorge Quarleri, M Victoria Delpino. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage. World Journal of Hepatology 2024; 16(1): 1-11 doi: 10.4254/wjh.v16.i1.1
Abstract(454) |
Core Tip(504) |
Full Article(HTML)(1907)
|
Full Article with Cover (PDF)-11949K(108)
|
Full Article (Word)-610K(20)
|
Audio-1342K(6)
|
Peer-Review Report-230K(73)
|
Answering Reviewers-97K(67)
|
Full Article (PDF)-1204K(130)
|
Full Article (XML)-236K(75)
|
Times Cited (0)
|
Total Visits (5164)
|
Open
|
| 12 |
Abdul Moeed, Muhammad Omar Larik, Muhammad Ahmed Ali Fahim, Hafsah Alim Ur Rahman, Lubna Najmi, Mah I Kan Changez, Muhammad Moiz Javed, Md Al Hasibuzzaman. Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review. World Journal of Hepatology 2024; 16(8): 1185-1198 doi: 10.4254/wjh.v16.i8.1185
Abstract(309) |
Core Tip(360) |
Full Article(HTML)(1526)
|
Full Article with Cover (PDF)-2631K(62)
|
Audio-649K(5)
|
Peer-Review Report-172K(49)
|
Answering Reviewers-186K(44)
|
Supplementary Material-19K(36)
|
Full Article (PDF)-605K(70)
|
Full Article (XML)-181K(50)
|
Times Cited (0)
|
Total Visits (3683)
|
Open
|
| 13 |
Neues zur Fettleber: Nomenklatur, Screening-Empfehlungen, Therapiebemühungen und andere klinisch relevante Aspekte. Zeitschrift für Gastroenterologie 2023; 61(10): 1419 doi: 10.1055/a-2149-7976
|
| 14 |
Dhanvee Balaji, Ranjith Balakrishnan, Dhasarathdev Srinivasan, Rajasekaran Subbarayan, Rupendra Shrestha, Nityanand Srivastava, Ankush Chauhan. The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments. Infectious Microbes and Diseases 2024; 6(4): 177 doi: 10.1097/IM9.0000000000000161
|